22-18078607-G-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001127649.3(PEX26):c.230+1G>T variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000083 in 1,445,478 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001127649.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- peroxisome biogenesis disorderInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- peroxisome biogenesis disorder 7A (Zellweger)Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- peroxisome biogenesis disorder 7BInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P
- Zellweger spectrum disordersInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001127649.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PEX26 | NM_001127649.3 | MANE Select | c.230+1G>T | splice_donor intron | N/A | NP_001121121.1 | |||
| PEX26 | NM_017929.6 | c.230+1G>T | splice_donor intron | N/A | NP_060399.1 | ||||
| PEX26 | NM_001199319.2 | c.230+1G>T | splice_donor intron | N/A | NP_001186248.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PEX26 | ENST00000399744.8 | TSL:1 MANE Select | c.230+1G>T | splice_donor intron | N/A | ENSP00000382648.4 | |||
| PEX26 | ENST00000329627.11 | TSL:1 | c.230+1G>T | splice_donor intron | N/A | ENSP00000331106.5 | |||
| PEX26 | ENST00000428061.2 | TSL:1 | c.230+1G>T | splice_donor intron | N/A | ENSP00000412441.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000830 AC: 12AN: 1445478Hom.: 0 Cov.: 30 AF XY: 0.00000418 AC XY: 3AN XY: 718374 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Peroxisome biogenesis disorder 7A (Zellweger) Pathogenic:2
Peroxisome biogenesis disorder 7B;C3888385:Peroxisome biogenesis disorder 7A (Zellweger) Pathogenic:1
This sequence change affects a donor splice site in intron 2 of the PEX26 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PEX26 are known to be pathogenic (PMID: 12851857, 21031596). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with Zellweger syndrome (PMID: 16257970, 27392320, 29947050). This variant is also known as intG231T. ClinVar contains an entry for this variant (Variation ID: 2159). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
Peroxisome biogenesis disorder Pathogenic:1
Variant summary: PEX26 c.230+1G>T is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a 5 prime splicing donor site. At least one publication reports experimental evidence that this variant affects mRNA splicing (e.g. Furuki_2006). The variant was absent in 213784 control chromosomes. c.230+1G>T has been reported in the literature in individuals affected with Zellweger Syndrome (e.g. Weller_2005, Furuki_2006, Daum_2019). These data indicate that the variant is likely to be associated with disease. At least two publications report experimental evidence evaluating an impact on protein function (e.g. Weller_2005, Furuki_2006). The most pronounced variant effect results in <10% of normal activity, with the Pex26 variant protein showing only residual protein import function in peroxisomes and immunoblots showing complete absence of protein in human proband fibroblast skin lines (Weller_2005). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at